Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials
Rosenfeld, Philip J., MD, PhD, Shapiro, Howard, PhD, Tuomi, Lisa, PharmD, Webster, Mary, BS, Elledge, Julee, BA, Blodi, Barbara, MD
Published in Ophthalmology (Rochester, Minn.) (01.03.2011)
Published in Ophthalmology (Rochester, Minn.) (01.03.2011)
Get full text
Journal Article